Cancer Research AACR Legacy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoon, S.-O.
Right arrow Articles by Mercurio, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoon, S.-O.
Right arrow Articles by Mercurio, A. M.
[Cancer Research 66, 6288-6295, June 15, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Ras Stimulation of E2F Activity and a Consequent E2F Regulation of Integrin {alpha}6ß4 Promote the Invasion of Breast Carcinoma Cells

Sang-Oh Yoon, Sejeong Shin and Arthur M. Mercurio

Division of Cancer Biology and Angiogenesis, Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts

Requests for reprints: Arthur M. Mercurio, Department of Cancer Biology, University of Massachusetts Medical School, LRB-408, 364 Plantation Street, Worcester, MA 01605. Phone: 508-856-8676; Fax: 508-856-1310; E-mail: arthur.mercurio{at}umassmed.edu.

Active Ras proteins contribute to breast carcinogenesis and progression. Here, we provide evidence that active H-Ras regulates the expression and activity of the E2F family of transcription factors in SUM-159 breast carcinoma cells. In addition, we show by using a DNA-binding mutant of E2F, as well as expression of specific E2Fs that are transcriptionally active, that the active E2Fs1-3 can mediate the H-Ras-dependent invasion of SUM-159 cells. The inhibitory E2Fs4-5, in contrast, do not influence invasion. One mechanism by which the active E2Fs promote H-Ras-dependent invasion seems to be their ability to increase expression of the ß4 integrin subunit, a component of the {alpha}6ß4 integrin that is known to enhance carcinoma invasion. Specifically, expression of E2Fs1-3 increased ß4 mRNA, protein, and cell surface expression. The active E2Fs were unable to stimulate invasion in cells that expressed a ß4 short hairpin RNA. This effect of the active E2Fs on ß4 expression does not seem to result from E2F-mediated ß4 transcription because the ß4 promoter lacks known E2F binding motifs. In summary, the data reported here indicate a novel mechanism by which H-Ras can promote the invasion of breast carcinoma cells. This mechanism links active H-Ras, transcriptionally active E2F, and the {alpha}6ß4 integrin in a common pathway that culminates in enhanced {alpha}6ß4-dependent invasion. (Cancer Res 2006; 66(12): 6288-95)




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
T. H. Kim, H. I. Kim, Y. H. Soung, L. A. Shaw, and J. Chung
Integrin ({alpha}6{beta}4) Signals Through Src to Increase Expression of S100A4, a Metastasis-Promoting Factor: Implications for Cancer Cell Invasion
Mol. Cancer Res., October 1, 2009; 7(10): 1605 - 1612.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Skuli, S. Monferran, C. Delmas, G. Favre, J. Bonnet, C. Toulas, and E. Cohen-Jonathan Moyal
{alpha}v{beta}3/{alpha}v{beta}5 Integrins-FAK-RhoB: A Novel Pathway for Hypoxia Regulation in Glioblastoma
Cancer Res., April 15, 2009; 69(8): 3308 - 3316.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Chen, M. Sinha, B. A. Luxon, A. R. Bresnick, and K. L. O'Connor
Integrin {alpha}6{beta}4 Controls the Expression of Genes Associated with Cell Motility, Invasion, and Metastasis, Including S100A4/Metastasin
J. Biol. Chem., January 16, 2009; 284(3): 1484 - 1494.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Blum, R. Elkon, S. Yaari, A. Zundelevich, J. Jacob-Hirsch, G. Rechavi, R. Shamir, and Y. Kloog
Gene Expression Signature of Human Cancer Cell Lines Treated with the Ras Inhibitor Salirasib (S-Farnesylthiosalicylic Acid)
Cancer Res., April 1, 2007; 67(7): 3320 - 3328.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.